Meeder Asset Management Inc Pfizer Inc Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

A detailed history of Meeder Asset Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Meeder Asset Management Inc holds 1,581 shares of PFE stock, worth $42,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,581

Previous 5,061 68.76%

Holding current value

$42,244

Previous $141,000 68.09%

% of portfolio

0.0%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$27.7 - $31.39 $96,396 - $109,237	-3,480 Reduced 68.76%	1,581 $45,000
Q2 2024 Aug 08, 2024	SELL	$25.26 - $29.6 $1.25 Million - $1.47 Million	-49,576 Reduced 90.74%	5,061 $141,000
Q1 2024 May 07, 2024	BUY	$25.89 - $29.73 $22,809 - $26,192	881 Added 1.64%	54,637 $1.52 Million
Q4 2023 Jan 25, 2024	SELL	$26.13 - $33.94 $2.14 Million - $2.77 Million	-81,747 Reduced 60.33%	53,756 $1.55 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $13,574 - $15,866	423 Added 0.31%	135,503 $4.49 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $5,309 - $6,143	147 Added 0.11%	135,080 $4.95 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $95,481 - $124,302	-2,424 Reduced 1.76%	134,933 $5.51 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $2.63 Million - $3.44 Million	-63,063 Reduced 31.47%	137,357 $7.04 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $95,790 - $116,936	-2,189 Reduced 1.08%	200,420 $8.77 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $170,299 - $201,922	3,660 Added 1.84%	202,609 $10.6 Million
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $9.1 Million - $11.3 Million	198,949 New	198,949 $10.3 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $11.7 Million - $17.3 Million	-282,198 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$39.25 - $50.42 $110,488 - $141,932	2,815 Added 1.01%	282,198 $12.1 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $177,969 - $201,610	4,956 Added 1.81%	279,383 $10.9 Million
Q1 2021 Apr 28, 2021	BUY	$33.49 - $37.77 $7.92 Million - $8.93 Million	236,391 Added 621.49%	274,427 $9.94 Million
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $7.58 Million - $9.64 Million	-226,422 Reduced 85.62%	38,036 $1.4 Million
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $156,051 - $183,083	4,915 Added 1.89%	264,458 $9.71 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $155,358 - $188,473	5,158 Added 2.03%	259,543 $8.49 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $1.94 Million - $2.77 Million	-71,848 Reduced 22.02%	254,385 $8.3 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $72,391 - $82,154	-2,199 Reduced 0.67%	326,233 $12.8 Million
Q3 2019 Oct 17, 2019	SELL	$32.49 - $42.13 $157,024 - $203,614	-4,833 Reduced 1.45%	328,432 $11.8 Million
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $382,040 - $428,943	10,331 Added 3.2%	333,265 $14.4 Million
Q1 2019 Apr 16, 2019	SELL	$37.5 - $41.2 $30,225 - $33,207	-806 Reduced 0.25%	322,934 $13.7 Million
Q4 2018 Jan 17, 2019	BUY	$38.47 - $43.86 $251,824 - $287,107	6,546 Added 2.06%	323,740 $14.1 Million
Q3 2018 Nov 02, 2018	BUY	$34.47 - $41.81 $839,482 - $1.02 Million	24,354 Added 8.32%	317,194 $0
Q2 2018 Jul 24, 2018	BUY	$32.98 - $35.16 $4.15 Million - $4.43 Million	125,874 Added 75.39%	292,840 $0
Q1 2018 May 03, 2018	BUY	$31.91 - $37.02 $3.41 Million - $3.95 Million	106,802 Added 177.52%	166,966 $5.93 Million
Q4 2017 Feb 02, 2018	BUY	$33.26 - $35.29 $157,585 - $167,204	4,738 Added 8.55%	60,164 $2.18 Million
Q3 2017 Oct 20, 2017	BUY	$31.0 - $34.15 $1.72 Million - $1.89 Million	55,426	55,426 $1.98 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Pfizer Inc Transaction History